AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is ...

AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...

While the numbers may seem high, they are still far below the pay of top executives in the United States, the study has found ...

He said about Britain that the firm needed “to see that there is access and a reason to invest.” This is partly a negotiating ...

FluMist has been approved since 2003, but, until last year, only for administration by a healthcare practitioner. The new nod ...

With the 2025-26 flu season around the corner, AstraZeneca is launching the first at-home seasonal flu vaccine.

Gov. Glenn Youngkin was in Petersburg to celebrate progress on the third anniversary of his 'Partnership for Petersburg' ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for AstraZeneca’s ...

AstraZeneca Vietnam has been recognised as one of the “Best Companies to Work for in Asia 2025” by HR Asia, underscoring its ...